Drugs / AIDSVAX
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00223080 Comparator | Oct 2003 → Jul 2006 | HIV infectious disease | U.S. Army Medical Research and Development Command | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AIDSVAX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00223080 ↗ |
| Modality | Vaccine | “recombinant glycoprotein 120 subunit vaccine (AIDSVAX B/E)” PMID 19843557 ↗ Oct 2009 |
| Route | Intramuscular | “ALVAC-HIV vCP1521 + AIDSVAX will both be administered by the intramuscular route” NCT00223080 ↗ |